New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.
about
Why prevent, diagnose and treat congenital toxoplasmosis?Clinically Available Medicines Demonstrating Anti-Toxoplasma ActivityT. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrestIn vitro effects of folate inhibitors on Toxoplasma gondiiGrowth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylaseZidovudine antagonizes the action of pyrimethamine in experimental infection with Toxoplasma gondiiIn vitro effects of sulfadiazine and its metabolites alone and in combination with pyrimethamine on Toxoplasma gondiiIn vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondiiIdentification of highly potent and selective inhibitors of Toxoplasma gondii dihydrofolate reductaseCharacterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiologyDelivery of antimicrobials into parasitesEvaluation of potential anti-toxoplasmosis efficiency of combined traditional herbs in a mouse modelIn vitro investigation of host resistance to Toxoplasma gondii infection in microglia of BALB/c and CBA/Ca miceSelective and strain-specific NFAT4 activation by the Toxoplasma gondii polymorphic dense granule protein GRA6.Toxoplasmosis in cardiac transplantationStudy of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazineIn vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondiiParadoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitroCyclosporin A: antiparasite drug, modulator of the host-parasite relationship and immunosuppressant.In vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii.Clindamycin in a murine model of toxoplasmic encephalitisDosage, timing, and route of administration of cyclosporin A and nonimmunosuppressive derivatives of dihydrocyclosporin A and cyclosporin C against Schistosoma mansoni in vivo and in vitro.Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study GroupEffect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in miceComparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.Sphingolipid synthesis and scavenging in the intracellular apicomplexan parasite, Toxoplasma gondiiEffect of three drugs against Encephalitozoon cuniculi infection in immunosuppressed miceCyclosporin A inhibits the growth of Cryptococcus neoformans in a murine modelPrevention of peroral and congenital acquisition of Toxoplasma gondii by antibody and activated macrophagesAntischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoniModification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.Effect of cytokines on growth of Toxoplasma gondii in murine astrocytesEnzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture.Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis.The panorama of cyclosporin research.Changes in enzyme activity and expression of DHFR of Toxoplasma gondii by antifolates.Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.
P2860
Q22305913-0B9C7411-0D4F-41F9-90B9-71E6874DD902Q26782581-88568816-A309-4A33-B893-22522A7333C7Q27316417-F95C7CBA-3CF4-4000-BD97-87B9B66D8062Q28342121-C0F9F3B9-7E6A-44F3-B957-E7384E41580AQ28343700-7BA020CA-94B3-46BA-A22B-6FA1149B73A8Q28356158-4B4407D1-40FE-4A4F-A925-F6AB00275828Q28368215-8203B438-8C1A-4D73-80D9-47F543F28BB2Q28369470-97B17166-4DCC-4237-B76B-77688CC9BC65Q28378350-D2157201-D597-4929-90AE-09666818FB9DQ28379120-535A8CFA-8707-4AD1-8EBA-A34B0D640FD5Q30493563-D781CF86-D9B8-43CF-8C24-D3E98FB055F4Q33827792-8BD4C8D5-7372-459D-B075-6E5FC8B4EE8CQ34005898-1723AA9B-3938-4BB0-9889-A2E678B1DE43Q34230563-9B972846-1BB2-476F-ABA4-0C964A4A399DQ34285304-73732305-ABBE-46CF-8FD4-F3C4753B65A2Q35110989-2BDF08CE-E5A4-47EC-BC81-538BB8C5FA49Q35116242-4B8787D1-376C-4034-9590-1E701F9BF7BFQ35124789-7DD03289-9BA8-4DDE-A261-EA9C7AD13B9DQ35137900-4C1A0CC0-DFED-4322-9D53-FC1609FBF6CCQ35224447-62DC1519-F1A4-4D30-9FD0-CB4233F33542Q35354962-DFE23F4C-E4FC-45B1-BF87-DA62563171A1Q35538321-86F09370-C618-4DBA-B22B-1893926CB264Q35542538-EAA72F7B-777B-4254-87E3-2B7D3F154F22Q35836203-BC95ADFC-B0D0-4B00-88E6-6BF170F3DFBFQ36753517-F64F1C24-2B92-4495-B33D-D8E307A37F4DQ36753766-5A924AA1-E987-4DB3-AB04-984B918D151DQ36775799-B8B99778-119E-45C6-803A-3618668D4553Q36969854-C97C0A95-0D82-4412-B73D-5E669B4853A4Q36992132-A1B26B23-A871-4DF9-8B95-7762766E7BE3Q36992479-4E3E4EA9-DFC9-475F-935C-6486ACFF50ACQ37027552-2136E8BB-FA3F-4AA2-9008-BC88D2AD634FQ37128281-000EC37C-1808-442E-9B63-E668AB6D7AEBQ39573333-D9C5FAB1-55F1-4176-8F32-F27211438FB1Q39817760-530916C7-90D2-4126-9EA3-FB44AB471E47Q39883651-5627C3B4-2ACA-4D54-BA9E-E8F6CF9C1954Q40165651-299A25AF-2E55-474F-A77D-B8BE605ACA21Q40865388-7F70498A-0D6A-4516-8D72-3EAFE5A80532Q41012181-166B6337-B5BB-482E-88D9-777A25E988DAQ41816370-C455E830-8C57-40E0-997F-FC1E9270F36AQ41968777-C9E656A7-0F0D-4402-B75A-8E49CEB02395
P2860
New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
New micromethod to study the e ...... ronidazole, and cyclosporin A.
@ast
New micromethod to study the e ...... ronidazole, and cyclosporin A.
@en
type
label
New micromethod to study the e ...... ronidazole, and cyclosporin A.
@ast
New micromethod to study the e ...... ronidazole, and cyclosporin A.
@en
prefLabel
New micromethod to study the e ...... ronidazole, and cyclosporin A.
@ast
New micromethod to study the e ...... ronidazole, and cyclosporin A.
@en
P2860
P356
P1476
New micromethod to study the e ...... ronidazole, and cyclosporin A.
@en
P2093
P2860
P356
10.1128/AAC.26.1.26
P407
P577
1984-07-01T00:00:00Z